Bionano Genomics, a life sciences instrumentation company, agreed to acquire Purigen Biosystems, a developer of an ionic purification system, for $64m. “We are thrilled to welcome the Purigen team to Bionano and look forward to working together to transform the way the world sees the genome. We believe the addition of the Ionic Purification System, its ITP technology and the Purigen team can enable Bionano to further simplify and streamline the process of DNA isolation for OGM and may also enable new applications for more sample types where low concentrations and small quantities of cells and the UHMW DNA they contain have proven to be challenging for our current solutions," Erik Holmlin, Bionano Genomics President and CEO.